Valuable Serum Markers in Pulmonary Alveolar Proteinosis

Table 6

The relationship between variations of DLCO-SB and variations of other parameters in PAP patients without inhalation of the GM-CSF treatment after six months of follow-up.

Variations of HDL-C (%)	-0.189	0.601
Variations of CEA (%)	-0.483	0.158
Variations of CY-21 (%)	-0.446	0.196
Variations of NSE (%)	-0.545	0.104
Variations of LDH (%)	-0.694	0.026